Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,717 public trials 2,164 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Active, not recruiting

Safety and Efficacy of Camrelizumab for High-risk NMIBC Failing BCG Treatment

NCT04706598

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Immunotherapy, +9 more
Locations
  • Shanghai Ninth People's Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
  • Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
  • Shanghai Tenth People's Hospital,Shanghai Tong Ji University School of Medicine Shanghai, Shanghai Municipality, China
  • Shanghai General Hospital,Shanghai Jiao Tong University School of Medicine Shanghai, Shanghai Municipality, China
View Trial Details
Active, not recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT06383390

Conditions
Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +34 more
Locations
  • Alabama Kidney Research Alabaster, Alabama, United States
  • Central Research Associates Birmingham, Alabama, United States
  • Alliance for Multispecialty Research, LLC Daphne, Alabama, United States
  • Nephrology Consultants Huntsville, Alabama, United States
View all 743 locations
View Trial Details
Active, not recruiting

Effect of Retatrutide Compared With Placebo in Participants With Type 2 Diabetes and Moderate or Severe Renal Impairment, With Inadequate Glycemic Control on Basal Insulin, With or Without Metformin and/or SGLT2 Inhibitor (TRANSCEND-T2D-3)

NCT06297603

Conditions
Chronic Disease, Diabetes Mellitus, Diabetes Mellitus, Type 2, +16 more
Locations
  • Nephrology Consultants Huntsville, Alabama, United States
  • Clinical Research Institute of Arizona (CRI) - Sun City West Sun City West, Arizona, United States
  • Kidney & Hypertension Center - Apple Valley Apple Valley, California, United States
  • Hope Clinical Research, Inc. Canoga Park, California, United States
View all 76 locations
View Trial Details
Active, not recruiting

Durvalumab+ Gemcitabine/Cisplatin (Neoadjuvant Treatment) and Durvalumab (Adjuvant Treatment) in Patients With MIBC

NCT03732677

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +9 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Los Angeles, California, United States
  • Research Site Palo Alto, California, United States
  • Research Site New Haven, Connecticut, United States
View all 188 locations
View Trial Details
Active, not recruiting

Intravesical BCG vs GEMDOCE in NMIBC

NCT05538663

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Fairbanks Memorial Hospital Fairbanks, Alaska, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • CTCA at Western Regional Medical Center Goodyear, Arizona, United States
View all 229 locations
View Trial Details
Active, not recruiting

Focused Radiation Versus Systemic Therapy for Kidney Cancer Patients With Limited Metastasis, SOAR Study

NCT05863351

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • UCHealth University of Colorado Hospital Aurora, Colorado, United States
  • Poudre Valley Hospital Fort Collins, Colorado, United States
View all 108 locations
View Trial Details
Active, not recruiting

Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

NCT04696731

Conditions
Adenocarcinoma, Advanced/Metastatic Clear Cell Renal Cell Carcinoma, Carcinoma, +15 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
  • UCSF Medical Center San Francisco, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
View Trial Details

Related conditions